Chorea is a movement disorder that causes unpredictable, involuntary movements resembling dance steps. Treatment focuses on managing symptoms, slowing progression when possible, and helping people maintain their independence and quality of life for as long as possible.

Understanding Treatment Goals for Chorea

When someone receives a diagnosis involving chorea, understanding the treatment landscape becomes essential for planning ahead. Chorea refers to involuntary, irregular movements that can affect the arms, legs, face, and other parts of the body. These movements are not just random jerks—they flow unpredictably from one body part to another, sometimes appearing as fidgeting, other times as more pronounced writhing or twisting motions.^[1]

The primary goal of treatment is not to cure chorea outright, as many of the conditions causing it cannot be reversed, but rather to control symptoms that interfere with daily activities. Treatment aims to reduce the severity of involuntary movements, improve the ability to perform everyday tasks like eating and dressing, and support emotional and mental well-being. Depending on the underlying cause—whether it’s a genetic condition like Huntington’s disease, a medication side effect, or an autoimmune disorder—the treatment approach will vary significantly.^[2]

Medical professionals follow established guidelines and recommendations when treating chorea. These guidelines are based on years of clinical experience and research into what helps patients most effectively. At the same time, researchers are continuously exploring new therapies through clinical trials, testing innovative drugs and approaches that may one day become standard care. For patients and families, this means there are both proven treatment options available now and promising possibilities on the horizon.^[8]

Treatment is highly personalized. Not everyone with chorea experiences the same symptoms at the same intensity, and the timing of symptom onset can vary widely. Some people may notice mild fidgeting that doesn’t significantly impact their life, while others may struggle with severe movements that make walking, eating, or speaking difficult. Healthcare providers consider the stage of disease, the specific symptoms present, and the individual’s personal goals when crafting a treatment plan.^[11]

Standard Treatment Approaches

The foundation of chorea treatment involves addressing the root cause whenever possible. For instance, if chorea results from a medication side effect—such as long-term use of antipsychotic drugs causing tardive dyskinesia—adjusting or stopping the offending medication may improve symptoms. Similarly, if chorea stems from a metabolic imbalance like abnormal blood sugar levels or thyroid problems, correcting these imbalances can reduce or eliminate the movements.^[1]

When the underlying cause cannot be fully treated, or when chorea is part of a progressive genetic condition, symptomatic treatment becomes the focus. The most widely used medications for reducing chorea are drugs that affect dopamine, a chemical messenger in the brain that plays a key role in controlling movement. The brain’s movement control center, called the basal ganglia, relies on a delicate balance of dopamine and other neurotransmitters. In chorea, this balance is disrupted, leading to excessive, uncontrolled movements.^[2]

Dopamine receptor blocking agents, also known as typical and atypical antipsychotics, work by preventing dopamine from binding to its receptors in the brain. This reduces the overactivity that causes chorea. Common medications in this category include haloperidol and fluphenazine (typical antipsychotics), as well as risperidone, olanzapine, and quetiapine (atypical antipsychotics). These medications can be effective at controlling movements, but they come with potential side effects such as drowsiness, weight gain, metabolic changes, and in some cases, worsening of movement problems or mood disturbances.^[8]

Another class of medications, called dopamine-depleting agents, works by reducing the amount of dopamine available in the brain. Three medications in this category have been particularly important for treating chorea associated with Huntington’s disease: tetrabenazine, deutetrabenazine, and valbenazine. These drugs inhibit a protein called vesicular monoamine transporter type 2 (VMAT2), which packages dopamine for release in the brain. By blocking this transporter, less dopamine is available to stimulate movement, thereby reducing chorea.^[12]

Tetrabenazine has been used for many years, but it requires multiple doses throughout the day and can cause side effects including depression, drowsiness, and worsening of other movement problems such as stiffness. Deutetrabenazine and valbenazine are newer versions that offer improved dosing schedules and may have fewer side effects. Deutetrabenazine is taken twice daily, while valbenazine can be taken once daily, making them more convenient for patients. Clinical studies have shown these medications can significantly reduce chorea severity and improve patients’ ability to perform daily activities.^[14]

In addition to dopamine-targeting medications, other drugs may be used as supplementary therapy. GABAergic drugs—medications that enhance the activity of gamma-aminobutyric acid (GABA), another brain chemical that helps calm nerve activity—can sometimes help. These include clonazepam (a benzodiazepine), gabapentin, and valproate. These are typically used alongside primary chorea medications rather than as first-line treatment.^[8]

For chorea caused by autoimmune conditions, such as systemic lupus erythematosus or antiphospholipid antibody syndrome, treatment targets the immune system rather than dopamine. Medications like corticosteroids (to reduce inflammation), plasma exchange (to remove harmful antibodies from the blood), or intravenous immunoglobulin (IVIG, which provides healthy antibodies) may be effective. These treatments work by calming the overactive immune response that is attacking the brain and causing chorea. In children with Sydenham chorea, which follows a streptococcal infection, similar immune-targeting treatments may shorten the illness and reduce symptom severity.^[2]

One important exception to symptomatic-only treatment is Wilson disease, a genetic disorder causing copper buildup in the body. When Wilson disease causes chorea, copper-reducing therapies can actually slow or halt disease progression, not just manage symptoms. This makes early diagnosis and treatment of Wilson disease particularly important.^[2]

Treatment duration varies widely depending on the cause of chorea. Some forms, like Sydenham chorea, may resolve completely with treatment and time. Others, like Huntington’s disease, require lifelong management with medications adjusted over time as the disease progresses. Regular follow-up with healthcare providers is essential to monitor treatment effectiveness and manage side effects.^[11]

Innovative Therapies in Clinical Trials

While standard medications help many people with chorea, researchers are actively investigating new approaches that could offer better symptom control, fewer side effects, or even disease modification. Clinical trials are research studies that test new treatments to determine if they are safe and effective before they become available to the general public.

Clinical trials typically progress through three phases. Phase I trials focus primarily on safety, testing a new treatment in a small group of people to understand what doses are safe and what side effects might occur. Phase II trials expand to a larger group and begin evaluating whether the treatment actually works to improve symptoms or slow disease progression. Phase III trials involve even larger groups of patients and compare the new treatment directly against standard care to determine if it offers meaningful advantages.^[6]

For Huntington’s disease, the most common genetic cause of chorea in adults, several innovative therapeutic approaches are being explored. One promising area is gene therapy and gene-targeting treatments. Since Huntington’s disease is caused by a mutation in the HTT gene, which produces an abnormal form of the huntingtin protein, researchers are investigating ways to reduce the production of this harmful protein. Techniques being studied include antisense oligonucleotides (ASOs), which are short pieces of genetic material that can bind to the messenger RNA from the mutant gene and prevent it from making the abnormal protein. By lowering levels of the toxic huntingtin protein, these treatments aim to slow down the death of brain cells and the progression of symptoms.^[7]

Another experimental approach involves targeting the cellular machinery that becomes dysfunctional in Huntington’s disease. Mitochondria, the energy-producing structures inside cells, don’t work properly in Huntington’s disease, and this contributes to brain cell death. Researchers have tested compounds like coenzyme Q10, which supports mitochondrial function, in clinical trials. While early studies in laboratory models showed promise, larger trials in human patients have not yet demonstrated clear benefits. However, research continues to refine these approaches and identify which patients might benefit most.^[8]

Some trials have explored combining multiple agents with complementary mechanisms. For example, coenzyme Q10 has been studied alongside minocycline, an antibiotic that also has effects on reducing cell death signals in the brain. The idea is that targeting multiple disease mechanisms simultaneously might produce better results than any single treatment alone. These combination approaches are still being evaluated for safety and effectiveness.^[8]

For chorea resulting from other causes, different therapeutic targets are being investigated. Researchers are studying new formulations of existing medications that might offer improved delivery to the brain, longer-lasting effects, or fewer side effects. Additionally, there is interest in understanding how inflammation in the brain contributes to chorea in various conditions, which could lead to new anti-inflammatory treatments specifically designed for movement disorders.^[11]

Clinical trials for chorea are conducted at medical centers around the world, including in the United States, Europe, and other regions. Patient eligibility for trials depends on many factors, including the specific cause of chorea, disease stage, previous treatments, and overall health. Some trials specifically seek participants with early-stage disease, while others focus on more advanced stages. Healthcare providers can help patients determine if there are appropriate clinical trials available and whether participation might be beneficial.^[6]

Surgical Interventions for Chorea

When medications don’t adequately control chorea, or when side effects from multiple medications become problematic, surgical options may be considered. The most extensively studied surgical approach for movement disorders is deep brain stimulation (DBS). This procedure involves implanting electrodes in specific areas of the brain that control movement, typically the globus pallidus internus or sometimes the thalamus. These electrodes are connected to a small device similar to a pacemaker, which is implanted under the skin in the chest. The device delivers carefully controlled electrical impulses to the targeted brain region, modulating the abnormal signals that cause chorea.^[8]

Deep brain stimulation has been used successfully for many years in Parkinson’s disease and other movement disorders. Its application in chorea, particularly Huntington’s disease-related chorea, is less established but has shown promise in some cases. Clinical reports have described improvements in choreiform movements following DBS, though results vary considerably between individuals. Some patients experience significant reduction in movements, while others see minimal benefit. The procedure appears to work best for chorea itself rather than other aspects of Huntington’s disease, such as cognitive decline or behavioral changes.^[8]

Researchers are still working to understand which patients are most likely to benefit from DBS and what stimulation settings work best for chorea. Different stimulation frequencies—for instance, 130 Hz versus 40 Hz—may produce different effects on chorea and on other movement problems that can coexist, like stiffness or slowness. Finding the optimal settings for each patient requires expertise and often involves a period of adjustment after the surgery.^[8]

DBS is considered when patients have disabling chorea that has not responded adequately to medications, when medication side effects are intolerable, or when patients need very high doses of multiple medications to control symptoms. It is not typically a first-line treatment. The surgical procedure carries risks including infection, bleeding, and complications related to the implanted device. Additionally, not all patients with chorea are good candidates for surgery, particularly if they have significant cognitive impairment or other medical conditions that would increase surgical risk.^[8]

Most common treatment methods

• Dopamine-depleting agents
  • Tetrabenazine, deutetrabenazine, and valbenazine block VMAT2 to reduce dopamine availability in the brain
  • These medications are specifically approved for treating chorea in Huntington’s disease
  • They typically reduce movement severity and improve ability to perform daily activities
  • Side effects can include depression, drowsiness, and worsening of stiffness
• Dopamine receptor blockers
  • Typical antipsychotics like haloperidol and fluphenazine block dopamine receptors
  • Atypical antipsychotics include risperidone, olanzapine, clozapine, and quetiapine
  • These medications can control chorea but may cause sedation, weight gain, and metabolic changes
  • Long-term use requires monitoring for additional movement problems
• GABAergic medications
  • Clonazepam, gabapentin, and valproate enhance calming signals in the brain
  • Often used as supplementary therapy alongside primary chorea medications
  • May help with both movement symptoms and anxiety
• Immunotherapy
  • Corticosteroids, plasma exchange, and intravenous immunoglobulin treat autoimmune chorea
  • Particularly important for conditions like systemic lupus erythematosus and Sydenham chorea
  • Works by reducing inflammation and removing harmful antibodies
• Deep brain stimulation
  • Surgical implantation of electrodes in movement-control areas of the brain
  • Electrical stimulation modulates abnormal brain signals causing chorea
  • Considered when medications are ineffective or cause intolerable side effects
  • Results vary significantly between individuals

Supporting Overall Health and Function

Medication and surgery are only part of comprehensive chorea treatment. Physical therapy, occupational therapy, speech therapy, and mental health support play crucial roles in maintaining quality of life and independence. These supportive therapies address the many ways chorea affects daily functioning beyond just reducing involuntary movements.^[15]

Physical therapy helps maintain strength, flexibility, balance, and coordination. While it cannot stop chorea itself, exercises prescribed by a physical therapist can help delay the worsening of balance problems and reduce fall risk. Therapists teach patients safe ways to move and may recommend assistive devices like walkers or canes when needed for stability. Regular, gentle exercise such as walking, swimming, or yoga can help maintain physical function for as long as possible.^[18]

Occupational therapy focuses on adapting daily activities to accommodate movement difficulties. Occupational therapists suggest modifications to the home environment that improve safety and independence. This might include removing tripping hazards, installing grab bars in bathrooms, using weighted utensils or plate guards to prevent spills during meals, and choosing clothing with easy-to-manage fasteners. These practical adjustments can significantly extend a person’s ability to care for themselves independently.^[16]

Speech therapy addresses difficulties with speaking clearly and swallowing safely. Chorea can affect the muscles used for speech and swallowing, making communication frustrating and increasing the risk of choking or aspiration (food or liquid entering the lungs). Speech-language pathologists work with patients on techniques to improve clarity of speech and safe swallowing strategies. They may recommend dietary modifications, such as adjusting food textures, to reduce choking risk.^[18]

Mental health support is essential because chorea often occurs alongside emotional and behavioral changes, particularly in conditions like Huntington’s disease. Depression, anxiety, irritability, and other mood disturbances can be as disabling as the physical symptoms. Psychiatrists can prescribe medications to help manage these symptoms, while psychologists and counselors provide talk therapy and coping strategies. Support groups, whether in-person or online, allow people with chorea and their families to connect with others facing similar challenges.^[15]

Nutritional support becomes increasingly important as chorea progresses. The constant involuntary movements burn extra calories, which can lead to unintended weight loss. People with chorea may need a higher-calorie diet than usual, with emphasis on nutrient-dense foods. Working with a registered dietitian can help ensure adequate nutrition and address swallowing difficulties that may develop. Some people benefit from eating smaller, more frequent meals, using adaptive utensils, and taking extra time for meals in a calm, distraction-free environment.^[17]

Creating a safe home environment reduces injury risk from falls or uncontrolled movements. Practical modifications include removing clutter and throw rugs, ensuring good lighting throughout the home, using non-breakable dishes and cups, installing nightlights, and placing non-slip mats in showers and tubs. These changes help people with chorea remain safely at home longer and maintain greater independence.^[18]

For people with genetic forms of chorea like Huntington’s disease, planning ahead is important. Making decisions about future care preferences, financial planning, and legal matters while cognitive function is still good allows individuals to maintain control over their care. Discussions about driving safety, work modifications or retirement, and living arrangements become necessary at various stages. Having open, honest conversations with family members and healthcare providers helps everyone prepare for changes that lie ahead.^[19]

Living with Chorea: Practical Strategies

Beyond medical treatments, many practical strategies can help people with chorea maintain their independence and quality of life. Establishing routines and consistent schedules helps with organization and reduces stress. Getting adequate rest is crucial—quality sleep supports both physical and mental health, and fatigue can worsen both chorea and cognitive symptoms. Creating a relaxing bedtime routine, keeping the bedroom cool and dark, limiting screen time before bed, and maintaining regular sleep-wake times all promote better sleep.^[17]

Staying mentally active through reading, puzzles, games, and social interaction may help preserve cognitive function longer. Engaging in hobbies and activities that bring joy improves quality of life significantly. While chorea may require adapting how activities are done—for example, using adaptive equipment for crafts or card games—continued participation in meaningful activities maintains a sense of purpose and connection.^[18]

Managing stress is particularly important because stress can temporarily worsen chorea symptoms. Relaxation techniques such as deep breathing exercises, meditation, guided imagery, or gentle movement practices like tai chi can help. Some people find that creative outlets like music, art, or journaling provide both stress relief and emotional expression.^[17]

Social connection remains vital. While chorea can make social situations challenging due to involuntary movements or communication difficulties, maintaining relationships with family and friends provides essential emotional support. Educating loved ones about chorea helps them understand what’s happening and how they can help. Many people find that being open about their condition reduces awkwardness and allows others to offer appropriate support.^[15]

For caregivers and family members, understanding chorea and its progression helps them provide better support while also taking care of their own needs. Caregiver burnout is real and can affect the quality of care provided. Support groups for caregivers, respite care services, and maintaining personal activities and relationships help caregivers sustain their ability to help over the long term.^[16]